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Background: Functional Strength Training (FST) could enhance recovery late after stroke. The aim of this study was
to evaluate the feasibility of a subsequent fully powered, randomized controlled trial.
Methods: The study was designed as a randomized, observer-blind trial. Both interventions were provided for up
to one hour a day, four days a week, for six weeks. Evaluation points were before randomization (baseline), after six
weeks intervention (outcome), and six weeks thereafter (follow-up). The study took place in participants’ own
homes. Participants (n = 52) were a mean of 24.4 months after stroke with a mean age of 68.3 years with 67.3%
male. All had difficulty using their paretic upper (UL) and lower limb (LL). Participants were allocated to FST-UL or
FST-LL by an independent randomization service. The outcome measures were recruitment rate, attrition rate,
practicality of recruitment strategies, occurrence of adverse reactions, acceptability of FST, and estimation of sample
size for a subsequent trial. Primary clinical efficacy outcomes were the Action Research Arm Test (ARAT) and the
Functional Ambulation Categories (FAC). Analysis was conducted using descriptive statistics and thematic analysis
of participants’ views of FST. A power calculation used estimates of clinical efficacy variance to estimate sample size
for a subsequent trial.
Results: The screening process identified 1,127 stroke survivors of whom 52 (4.6%) were recruited. The recruitment
rate was higher for referral from community therapists than for systematic identification of people discharged
from an acute stroke unit. The attrition rate was 15.5% at the outcome and follow-up time-points. None of the
participants experienced an adverse reaction. The participants who remained in the study at outcome had received
68% of the total possible amount of therapy. Participants reported that their experience of FST provided a sense of
purpose and involvement and increased their confidence in performing activities. The power calculation provides
estimation that 150 participants in each group will be required for a subsequent clinical trial.
Conclusions: This study found that a subsequent clinical trial was feasible with modifications to the recruitment
strategy to be used.
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People often experience permanent disability after stroke
that impacts adversely on everyday life. Indeed, stroke
leaves about 66% of survivors with long-term limb im-
pairments [1]. This is an unsatisfactory outcome that
could be ameliorated by the provision of task-specific re-
training of everyday function [2]. Participation in func-
tional re-training, however, requires the production of
sufficient voluntary activation of paretic muscle to attain
the muscle strength thresholds required for everyday
activity [3]. Strength training is therefore also used after
stroke and has been found to enhance recovery [4,5] and
maintain this for up to four years after stroke [6]. There
are potentially even better effects if strength training is
combined with task-specific training [3]. Initial evidence
suggests that functional strength training (FST) com-
pared with rehabilitation as usual could enhance upper
limb (UL) recovery [7] for people up to three months after
stroke, although it might provide little advantage for the
lower limb (LL) [8], except for habitual gait speed [9]. FST
has also been found to enhance walking function when
compared with no intervention in people who are at least
one year after stroke and able to walk 10 m independently
[10]. It is unknown whether or not FST might enhance
the motor function of people who are unable to walk
10 m independently and are in the so-called chronic stage
after stroke.
The emergent hypothesis is that people who are six
months or more after stroke improve motor function in
response to FST. The first step in testing this hypothesis
is presented in this article, which reports a feasibility study
as a precursor to a subsequent clinical trial [11-13]. The
specific objectives were: to estimate the recruitment and
attrition rates for a subsequent clinical trial; to assess and
refine the practicality of a participant recruitment strategy
for use in a subsequent clinical trial; to assess the occur-
rence of potential adverse reactions to FST provided for
people in their homes between six months and five years
after stroke; to assess the acceptability of delivering FST to
stroke survivors in their homes through (a) eliciting par-
ticipants’ opinions of their expectations and experiences
and (b) recording fidelity to the intervention protocol; to
inform a power calculation to estimate the sample size for
a subsequent clinical trial with data of clinical efficacy,
and its variance, of FST to enhance upper and lower limb
motor function in people who are six months to five
years after stroke; and to explore the feasibility of col-
lecting resource use and quality of life data to inform
the design of the health economics component of a fu-
ture definitive trial.
Methods
A summary of the methods is given here. A full descrip-
tion is given in the published protocol [14].Design, setting, randomization, and ethics
The design was a two-group, randomized, observer-blind,
feasibility study based in participants’ own homes with an
embedded qualitative investigation of participants’ expecta-
tions and experiences of FST. The assessor, who conducted
the efficacy and health economics measurement battery at
baseline, outcome, and follow-up time-points, remained
blinded to participants’ group allocation throughout the
trial. A research therapist provided participants with their
allocated intervention for up to one hour a day, four days a
week, for six weeks. Measures were repeated on comple-
tion of the intervention phase (outcome) and six weeks
thereafter (follow-up).
Participants were recruited from the discharge database
of one acute stroke service, the six-month post-stroke
clinic of the same stroke service, and therapist referral.
After providing informed consent, participants under-
took the measurement battery (baseline). An independ-
ent randomization service concealed group allocation
until contacted by a researcher, and then used the base-
line scores for the Functional Ambulation Category
(FAC) [15] and Action Research Arm Test (ARAT) [16]
to minimize any imbalance in allocation of participants
to either FST-UL or FST-LL. In this study the FAC was
categorized as: mild (score of 4 or more - walks inde-
pendently on level ground but requires assistance with
for example, stairs and slopes), moderate (score of 3 -
requires the verbal supervision and/or stand-by help of
one person), or severe (score of 2 or less - continuous
or intermittent assistance of one person required). The
ARAT was categorized as: mild (score between 39 and
57, when 57 indicates normal completion of all items),
moderate (score between 20 and 38, when 38 equates to
ability to complete all items albeit slowly and/or abnor-
mally), or severe (score between 0 and 19, when 19 indi-
cates the ability to complete all items in part). Allocating
participants to one of two experimental groups, FST-UL
or FST-LL, was used to minimize the potential con-
founder of one group receiving less therapy than the other
and an inactive therapy [14]. Although some clinicians
highlighted to the researchers that they expected a
cross-training effect between the upper and lower limbs,
such an interaction is not supported by clinical research
evidence [14,17].
Ethical approval was granted by the Norfolk Ethics
Committee (reference number 09 H0308 147). The
Current Controlled Trials registration identifier is
ISRCTN71632550.
Study population and sample size
Study criteria were similar to those in our earlier studies
conducted with people who were early after stroke [7,8]:
aged 18 years and over, between six months and five years
after a stroke (infarct or hemorrhage) in the anterior
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walk four steps with support from one person and/or an
assistive device, but in 15 seconds unable to step on and
off a 7.5 cm high block, with either leg, more than 14
times (Step Test) [18]; able to move the paretic hand from
lap to table surface, but unable to pick up £1 coins indi-
vidually and stack four in an even pile; able to follow a
one-stage command with the non-paretic upper limb; no
known pathology contraindicating participation in FST;
and not participating in formal upper or lower limb phys-
ical therapy.
To provide data for a subsequent sample size calcula-
tion we required at least 30 participants to estimate pa-
rameters of interest [19] as hypothesis testing is not the
focus of a feasibility study [13]. In order to provide some
assurance that our sample size would provide sufficient
data for a power calculation, a preliminary power calcu-
lation estimated that 26 participants per group would
have 90% power at 5% significance (two-tailed) to detect
a change of: 1 point on the FAC [15] with the assump-
tion that the standard deviation (SD) would be 1, and
5.7 points on the ARAT [16], with the assumption that
the SD would be 5.7 [20].
For exploration of the expectations and experiences of
undertaking FST we used purposive sampling [21] to re-
cruit six of the participants to an embedded qualitative in-
vestigation. The purposive selection criteria were people
receiving FST-UL and those receiving FST-LL, both
women and men, participants across the age range rep-
resented in the study cohort, and participants with dif-
ferent ability in functional use of the paretic upper and
lower limb.
Functional strength training
FST provided in the present study has been previously
described [7,8,14]. In essence, it involves repetitive pro-
gressive resistive exercise during functional task-specific
training [7,8,14]. Examples of FST-UL exercises used in
this trial include variations of: reaching, picking up a jug
containing water and pouring contents into a container;
picking up a container and removing the screw lid; reach-
ing down to a foot and then using both hands to lace up a
shoe; and picking up and then moving everyday objects of
various weights and sizes to position them in a different
locations of diverse heights.
Examples of FST-LL exercises used in this trial include
variations of: standing up and sitting down; ascending
and descending stairs and/or using a block for step up/
step down exercise; practice of balance activity including
one-leg standing; and walking whilst avoiding and/or
stepping over obstacles.
Activities were progressed systematically, increasing
the amount of resistance and number of repetitions. Re-
sistance was varied using external resistance bands and/or weights and also increasing task difficulty through
strategies such as decreasing seat height for sit or stand
activities and increasing or decreasing the requirement for
hand grip span. Progression was informed by the Oxford
program [22]. This provided a framework for advancing
the strengthening program. In practice, as the objects used
to create loading were often functional items such as bot-
tles, or functional tasks such as sit-to-stand, the therapist
judged when the participant was easily able to achieve ten
repetitions and would then increase the load or the diffi-
culty of the task so that the strengthening program was
progressed. If participants became fatigued, which was
assessed as an increasing difficulty in performing the ac-
tivity and/or self-reported feelings of tiredness, the therap-
ist initially changed activities or offered a rest period until
either one-hour of therapy was completed or it became
apparent that the participant was unable to continue with
the intervention that day.
Participants’ expectations and experiences of undertaking
functional strength training
An experienced qualitative researcher undertook semi-
structured audio-taped interviews with participants in their
own homes, at the baseline and outcome time-points. The
full interview schedule is available in the published proto-
col [14]. In summary, they used indicative questions to ex-
plore participants’ stories of their life before the stroke, the
experience of having a stroke, thoughts about the recovery
process, their expectations of FST (baseline only), and ex-
periences of participating in FST (outcome only). Partici-
pants were encouraged to raise issues they perceived to be
pertinent about their stroke, their recovery, their lives, and
the FST they received.
Outcomes
Data were collected to calculate the recruitment and at-
trition rates, assess the productivity of recruitment strat-
egies, monitor adverse reactions in both groups, identify
and record participants’ expectations and experiences, and
assess the total amount (hours) of FST received by partici-
pants compared to the total possible amount.
For adverse reactions it was specifically postulated that
paretic limb pain could occur if FST was provided in a
dose (amount in hours) that was too much for a partici-
pant. Pain was considered an adverse reaction if the
therapist providing FST received a verbal or behavioral
report of pain on four consecutive treatment days. Par-
etic limb pain was included in the monitoring as it was
highlighted to the research team that this was a specific
clinical concern.
For the cost-effectiveness aim of this feasibility study,
we employed a purpose-designed cost questionnaire (these
have been submitted to the Database of Instruments for
Resource Use Measurement) and the EuroQol-5D (EQ-
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pants at the baseline, outcome, and follow-up time-points.
Sample size for a subsequent clinical trial was estimated
using a power calculation informed by clinical efficacy
data. The primary outcomes were the FAC [15] for lower
limb function and the ARAT [16] for upper limb function.
Secondary outcomes were the Modified Rivermead Mobil-
ity Index (MRMI) [24] and the Timed Up and Go Test
(TUG) [25] to assess mobility, and the Nine Hole Peg Test
(9HPT) [26] to assess hand dexterity.
Analysis
The recruitment rate was calculated as the percentage of
people screened who were eligible for the study and sub-
sequently provided informed consent. The attrition rate
was calculated as the percentage of those recruited who
did not undertake the measurement battery at the out-
come and follow-up time-points. The practicality of the
recruitment strategies was judged by consideration of
the recruitment rate of each strategy.
The occurrence of potential adverse reactions to FST
was judged by the percentage of participants who experi-
enced one or more adverse reactions. This was analyzed
for the whole sample and by allocation group. The ac-
ceptability of FST to participants was assessed by con-
sidering the participant’s’ opinions of their expectations
and experiences of FST together with the percentage of
the possible total amount of FST that was received by
participants.
Information for estimation of the sample size for a sub-
sequent clinical trial was provided by calculation of the
clinical efficacy, and its variance, of FST-LL and FST-UL.
First, a full-case analysis was performed in which all indi-
viduals with data at the outcome time-point were included
according to the assigned treatment group. Second, an
intention-to-treat analysis with all individuals included
was conducted by imputing the values for those missing.
The method for imputing the missing data was iteratively
chained equations with all outcome measures included,
prognostic baseline factors, and treatment group [27].
ARAT data was analyzed by ranking each individual
and comparing the mean rank, based on a regression
model with the minimization variables included, between
the two groups. The P-value and confidence interval were
estimated using the non-parametric bootstrap [28]. FAC
categories were compared using the proportional odds
model with group and minimization variables included.
The proportional odds model assumption was tested. FAC
categories were further categorized to ensure that suffi-
cient numbers were included in each category; the classifi-
cation was 0 to 1, 2 to 3, and 4 to 5. The MRMI data were
compared between groups using the same approach out-
lined above for ARAT. The TUG data were analyzed by
firstly comparing those individuals who could completethe task, and then by comparing the time using a log-
transformed linear regression model including group and
the minimization variables. A logarithmic transformation
was used as the TUG data was positively skewed. Data for
the 9HPT were analyzed by comparing the number of
people in each group who could complete all 9 pegs in
50 seconds on at least one of three attempts.
To estimate the parameters needed for a formal sam-
ple size calculation for a subsequent pragmatic trial, the
variation in outcome measure was estimated from the pri-
mary analysis and the recruitment and attrition rates pre-
dicted from those in this trial. The analysis was undertaken
according to the predefined statistical analysis plan, agreed
with the Trial Steering Committee prior to the unblinding
of the data. Hence the differences in the specific statis-
tical tests as described in the published protocol [14].
The feasibility of collecting resource use and quality of
life data was assessed via the completion rates for the
cost-questionnaires and EQ-5D at each of the time points.
Study management
A Trial Steering Committee (TSC) provided oversight of
this feasibility study. The TSC Chair was independent of
the research team. Meetings of the TSC were held through-
out the course of the study to ensure adherence to Good
Clinical Practice requirements and to monitor recruitment,
attrition, and adverse reactions to FST. As this was a
feasibility study, a formal data monitoring committee
was not convened.
Service user involvement
A local stroke service users forum reviewed a protocol
for this feasibility study and their comments were incor-
porated into the final version submitted for external
peer-reviewed research funding. The stroke service users
welcomed investigation of therapy provided in peoples’
own homes and had no concerns about the intervention.
Once research funding was obtained, ongoing public
involvement was provided by the Patient and Public
Involvement in Research Group (PPIRES, South Norfolk
Clinical Commissioning Group, UK.).
Results
Baseline characteristics of participants
Table 1 provides participants’ characteristics. In summary,
participants were a mean of 24.4 months after stroke with
a mean age of 68.3 years. The median score for ARAT was
15.7 (total possible = 57) and for FAC was 2.5 (total pos-
sible = 5). All characteristics were balanced across the two
groups except for stroke classification. The FST-UL group
had a higher percentage of people clinically classified as
having a partial anterior circulation stroke and the FST-LL
had a higher percentage of people as having a lacunar
Table 1 Baseline characteristics of all randomized
participants
FST-UL
(n = 27)
FST-LL
(n = 25)
Age in years* 67.6 (12.9) 69.0 (13.7)
Months since stroke* 24.4 (16.6) 24.4 (13.7)
Gender#
Male 18 (66.7) 17 (68.0)
Female 9 (33.3) 8 (32.0)
Hemiside#
Left 15 (55.6) 12 (48.0)
Right 12 (44.4) 13 (52.0)
Stroke classification#
LACS 6 (22.2) 9 (36.0)
PACS 12 (44.5) 9 (36.0)
TACS 3 (11.1) 6 (24.0)
POCS 3 (11.1) 1 (4.0)
hemorrhage 3 (11.1) 0 (0)
Action Research Arm Test+ 16.7 (13.5) 14.8 (12.9)
Able to complete Nine Hole Peg Test# 1 (3.9) 0 (0)
Functional Ambulation Categories#
0 3 (11.1) 2 (8.0)
1 4 (14.8) 5 (20.0)
2 8 (29.6) 7 (28.0)
3 1 (3.7) 2 (8.0)
4 11 (40.7) 9 (36.0)
5 0 0
Modified Rivermead Mobility Index+ 26.8 (3.4) 26.1 (4.4)
Timed Up and Go Test* 42.3 (31.5) 49.3 (36.8)
*mean (standard deviation); #number of participants (%); +median
(interquartile range). FST-UL = Functional Strength Training for Upper Limb;
FST-LL = Functional Strength Training for Lower Limb; LACS = lacunar anterior
circulation stroke; PACS = partial anterior circulation stroke; ST-UL = Functional
Strength Training for Upper Limb; TACS = total anterior circulation stroke.
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tion relating to recruitment strategy feasibility).
The six participants involved in the qualitative investi-
gation were in the age range of 41 to 80 years, three
were male, and four were allocated to FST-LL. Full de-
tails are provided in Table 2.Table 2 Characteristics of participants in the qualitative inves
Gender Age group (years) FST group
Male 51-60 FST-UL
Male 51-60 FST-LL
Female 41-50 FST-LL
Female 71-80 FST-LL
Female 71-80 FST-LL
Male 51-60 FST-ULRecruitment and attrition
Recruitment took place over a two-year period (March
2010 to March 2012). The first participant was recruited
on 4 March 2010, with the final participant being re-
cruited on 19 March 2012 and the final follow-up meas-
ure taken on 19 July 2012.
The CONSORT flowchart gives details of screening,
recruitment, and attrition during this feasibility trial
(Figure 1). In brief, 1,127 stroke survivors were assessed
for eligibility and 1,075 were excluded. The remaining
52 provided informed consent and were randomized,
providing a recruitment rate of 4.6%.
Twenty-seven participants were allocated to FST-UL
with all receiving their allocated intervention, and 25 to
FST-LL with 23 receiving their allocated intervention
(one person declined the allocated intervention and one
became unwell). Attrition rates were 11% and 15% for
FST-UL and 20% and 16% for FST-LL at outcome and
at follow-up, respectively. The mean attrition rate at out-
come was therefore 15.5% at outcome and follow-up for
the entire sample.
Practicality of participant recruitment strategies
After the first four months of recruitment it became ap-
parent that the study was not meeting the intended re-
cruitment rate. Two people had been recruited whilst
the target was eight by that point. Consequently, the de-
cision was made to also recruit participants via referrals
from both the stroke Early Supported Discharge team
(ESD) and from therapists providing healthcare for stroke
survivors in other parts of community services (therapist
referral). The majority of participants were recruited via
therapist referral (69%) whilst no referrals were made from
the ESD. Other measures to improve the recruitment rate
included securing funding from the Comprehensive Local
Research Network for increased administration support in
order to increase the number of invitation letters that
were sent out. This secured 27% of referrals, with the
remaining 4% evenly distributed between referral via a
friend who had already participated in the study and a
poster that had been displayed in a local clinical setting.
Although the recruitment rate was increased with the
therapist referral strategy for those participants it was
not possible to access the neuroimaging information in atigation of their expectations and experiences of FST
Household type Residential area type
Single, living with friends Urban estate
Married, living with wife Rural
Separated, living with partner Rural town
Single, living alone Rural town
Widowed, living alone Rural town
Divorced, living with lodgers Suburban
Figure 1 Trial flowchart. FST-UL = functional strength training for the upper limb; FST-LL = functional strength training for the lower limb.
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sion or otherwise was based on clinical presentation.
This resulted in the inclusion of four participants, subse-
quently identified to have a stroke affecting the posterior
circulation (Table 1).
Occurrence of adverse reactions to FST
None of the participants experienced an adverse reaction.
Acceptability of FST
All participants received the intervention as allocated
except one participant who withdrew from the FST-LL
group as he wanted FST-UL. The content of FST-UL
and FST-LL was consistent with the protocol (Table 3)
and the amount of therapy was essentially the same in
the two groups (Table 4).
The intervention was embraced by qualitative study
participants without exception. They expressed entirely
positive views about the potential benefits it might
bring to their lives. They viewed participation in the
study as a way of accessing further rehabilitation whichthey perceived as lacking since their discharge from
hospital. Two major themes emerged from the data re-
garding the experience of FST; these concerned an in-
crease in their confidence regarding activities and a
sense of purpose and involvement, as one man com-
mented about goal setting:
‘I need someone saying P you have got to do this and
take my arm and put it where it ought to be and say
this is what you are trying to get to’ (male participant
P152).
Most of these perceptions seemed to be conditional on
the characteristics of those therapists who delivered the
intervention, as with their listening skills:
‘I have tried to do this and I just can’t do this and
they listen to you and then you know you would just
keep going’ (female participant P126).
But there was some evidence of their developing
increased self-efficacy that persisted into the follow-up
Table 3 Content of functional strength training for
participants who completed both baseline and outcome
measures: percentage of total therapy time
Group allocation
FST-UL FST-LL
FST-UL provided 54.5 NA
Functional movement training – upper limb 26.0 NA
Focus primarily on resistance during function 8.7 NA
Facilitation upper limb activity from another
body part
5.6 NA
Focus on cueing 5.2 NA
Gravity-neutral repetitive movement
FST-LL provided NA 67.8
Functional movement training – lower limb NA 13.8
Focus primarily on resistance during function NA 10.9
Performance of specific movement patterns NA 7.5
Promotion muscle activity and joint movement
during function
54.5 NA
FST-UL = Functional Strength Training for Upper Limb; FST-LL = Functional
Strength Training for Lower Limb; NA = not applicable.
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realize these plans:
‘I’ve been thinking about getting into town but now
I’ve got more confidence to do it’ (female participant
P141).Table 4 Functional strength training for participants who
completed both baseline and outcome measures:
time-duration and reasons for missing entire sessions
Allocated group
FST-UL FST-LL
Hours of FST-UL for 24 participants
Total delivered 410.2 NA
Total planned 576.0 NA
Percentage of planned that was delivered 71.3% NA
Mean delivered per participant 17.1 NA
Hours of FST-LL for 19 participants
Total delivered NA 325.7
Total planned NA 504.0
Percentage of planned that was delivered NA 64.6%
Mean delivered per participant NA 17.1
Reasons for missed sessions (% of planned sessions)
Participant unwell 2.8% 2.4%
Participant cancelled 5.4% 7.5%
Therapist unavailable 2.8% 3.6%
Annual leave/bank holiday 0.7% 1.1%
Data unavailable 0% 0.8%
FST-UL = Functional Strength Training for Upper Limb; FST-LL = Functional
Strength Training for Lower Limb; NA = not applicable.Sample size for subsequent clinical trial
Table 5 displays the results for the primary and secondary
outcomes. There was a significant difference in the ARAT
scores between the groups, with the lower limb group
having a lower score at both outcome (P = 0.042) and at
follow-up (P = 0.019). The effect sizes were −5.06 (95%
CI −9.93 to –0.18) and −5.91 (95% CI −10.85,to –0.97) re-
spectively. There was no difference in the FAC scores be-
tween the groups at either outcome (P = 0.654) or at
follow-up (P = 0.925). The proportional odds assumption
for FAC was tested and no reason was identified to reject
the fit of the model (outcome: P = 0.964; follow-up: P =
0.821). The only other outcome to show a significant dif-
ference was the TUG at outcome (P = 0.047), with the
upper limb group completing the test in a shorter time
(effect size 1.61 (95% CI 1.01 to 2.59). In addition, fewer
individuals in the lower-limb group could complete the
TUG (100% and 80% respectively) although this was not
significantly different (P = 0.169). The results of the im-
puted data, in terms of the effect sizes and significance
levels, are similar to those of the observed and are there-
fore not presented.
Using the standard deviation data from ARAT and FAC
scores from this trial and the dropout rate, the estimated
sample size to provide 90% power at 5% significance for a
subsequent multicenter trial is 150 participants per group
to detect a 5.7 unit change in ARAT, and 57 per group to
detect a 1.0 unit change in FAC.
Completion rates for the cost-questionnaires and EQ-5D
At baseline, all of the LL and UL participants completed
both the cost questionnaire and EQ-5D. At outcome, 21
out of 25 of the LL participants (84.0%) completed both
of these measures, compared to 24 out of 27 UL partici-
pants (88.9%). The same rates were achieved at follow-
up. Additionally, the therapists who delivered the FST
intervention provided data for consultation times for all
of the LL and UL participants.
Discussion
This feasibility study has provided important information
for a subsequent clinical trial. Design of a subsequent trial
will be informed by the estimates from current findings of
a recruitment rate of 5%, and attrition rates of 11% for
FST-UL and 20% for FST-LL at the primary time-point
after the six-week intervention phase. The findings re-
ported here indicate that the recruitment strategy for a
subsequent trial needs to consider that referral from ther-
apists might produce the greatest yield, however a process
for accessing neuroimaging data in a timely manner is
needed in order to confirm the location of the stroke.
None of the participants experienced an adverse reaction
to FST and whilst this does not provide robust evidence of
safety, when considered with the data from participant
Table 5 Outcome scores over time for both groups
Outcome Follow-up
FST-UL (n = 24) FST-LL (n = 25) Effect size for
difference
between groups
P-value+ FST-UL (n = 23) FST-LL (n = 21) Effect size P-value
N Mean
(SD)/N (%)
N Mean
(SD)/N (%)
N Mean
(SD)/N (%)
N Mean
(SD)/N (%)
Primary outcomes
ARAT 24 22.9 (14.2) 19 14.2 (14.0) −5.06 (−9.93,-0.18)* 0.042 23 21.0 (14.9) 20 15.6 (14.2) −5.91 (−10.85,-0.97)* 0.019
FAC 24 20 23 21
0 3 (12.5) 1 (5.0) 0.73 (0.18,2.89)# 0.654 4 (17.4) 2 (9.5) 0.94 (0.24,3.69)# 0.925
1 2 (8.3) 6 (30.0) 3 (13.0) 5 (23.8)
2 5 (20.8) 4 (20.0) 4 (17.4) 4 (19.1)
3 1 (4.2) 0 (0.0) 0 (0.0) 2 (9.5)
4 13 (54.2) 9 (45.0) 12 (52.2) 8 (38.1)
Secondary outcomes
MRMI* 19 26.5 (4.7) 19 26.4 (2.0) −3.2 (−10.0,3.7)* 0.367 18 27.3 (3.1) 20 26.5 (3.9) 0.49 (−4.75,5.72)* 0.856
TUG - time (secs)1 20 26.1 (17.1) 19 47.1 (35.0) 1.61 (1.01,2.59)+ 0.047 19 37.1 (30.3) 18 39.8 (28.3) 0.93 (0.72,1.21)§ 0.592
TUG - ability to complete 2 24 20 (82.6) 20 19 (90.5) 5.35 (0.49,58.21) 0.169 23 19 (82.6) 20 17 (85.0) 1.53 (0.25,9.35) 0.648
9HPT - ability to complete2 24 1 (4.2) 17 0 (0.00) NA 1.0003 23 1 (4.4) 0 0(0.00) NA 1.0003
+P-value for difference between treatment groups; *mean difference in rank; #common odds ratio for a one unit increase; §ratio of means;; 1the average of those times taken to complete the task; 2the ability to
complete the task at least once; 3based on Fisher’s exact test ignoring factors used in minimization. 9HPT = Nine Hole Peg Test; ARAT = Action Research Arm Test; FAC = Functional Ambulation Categories; FST-LL = Functional
Strength Training - Lower Limb; FST-UL = Functional Strength Training - Upper Limb; MRMI =Modified Rivermead Mobility Index; TUG = Time Up and Go Test;
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late after stroke in their own homes is practical. Incorpor-
ating health economics measures in a subsequent trial is
likely to provide sufficient data as both the cost question-
naire and EQ5D were completed by 84% of the FST-LL
and 89% of the FST-UL participants. The sample size for a
subsequent trial is estimated, based on actual data from
this feasibility trial, as 150 participants per group.
The recruitment rate of 5% to the present trial was
lower than the 9% and 10% of the two earlier trials of
FST [7,8]. The present trial recruited people who were
living at home a mean of two years after stroke com-
pared with people in an in-patient rehabilitation facility
a mean of 20 [7] and 34 [8] days after stroke. Another
potential influential factor could be that previous studies
[7,8] used face-to-face recruitment methods whereas we
made first contact with people via a letter [14]. Recruit-
ment rate to a subsequent trial might be higher, therefore,
if face-to-face screening could be conducted. However,
this is likely to be more costly in terms of travel to the
homes of potential participants and researcher time. In
addition, it would still require first contact to be via a
letter in order to arrange a suitable visit time. Other strat-
egies which may increase recruitment are: telephone re-
minders, use of opt-out procedures rather than opt-in,
and participants knowing which intervention they receive
[29]. Neither telephone reminders nor opt-out procedures
were used in this feasibility trial. Opt-out procedures are
difficult, if not impossible, to apply to exercise-based inter-
ventions and so this is unlikely to be a useful strategy. This
leaves telephone reminders to non-respondents to the let-
ters sent to inform stroke survivors about the trial, al-
though this will require careful consideration in a research
governance environment which safeguards people from
unwanted intrusions. However, 63% of people surveyed
about their attitudes to participation in clinical trials re-
ported that they consider it appropriate to be contacted
by telephone [30]. A potential way forward could be to
conduct pretrial focus groups which have been found to
provide useful information for the design of trial re-
cruitment strategies [31].
A recruitment strategy used in a subsequent trial will
need to consider the challenge encountered during this
feasibility trial of ensuring timely access by research thera-
pists to neuroimaging data held in the hospital hosting the
acute stroke unit. This challenge arose when participants
were recruited through referral from community-based
therapists who did not have access to neuroimaging data
or detailed medical notes. The process adopted was that
used in clinical community practice whereby therapists
make assessments based mainly on behavioral clinical
presentation. This procedure resulted in the inclusion of
four participants who were subsequently found to have
stroke in the posterior not anterior circulation territory.This protocol deviation needs to be avoided. Any strategy
needs to consider that a subsequent trial of FST in a
community setting should recruit participants using cri-
teria that can be replicated in clinical practice [32]. It is
intended to explore this challenge with healthcare pro-
fessionals working in stroke services in both acute and
community settings.
A strong design aspect of the present trial is avoidance
of the potential confounder of comparing experimental
treatment to no treatment or to a conventional treatment
of lower dose [33]. The potential confounding factor of
treatment intensity [34] was also avoided.
Participants’ adherence to the planned interventions was
greater than in the earlier trials. A mean of 17.1 hours of
therapy for participants in the FST-UL group compared to
12.5 hours [7], and 17.1 hours for those in the FST-LL
group compared to 14.8 hours [8]. This equates to 71%
and 65% completion of intervention planned for FST-UL
and FST-LL respectively. Interestingly, a study of a simi-
lar lower limb intervention with people who were a
mean of 63 months after stroke reported 100% compli-
ance with the planned intervention [10]. Although par-
ticipants in the earlier study were all able to walk 10 m
at baseline and the intervention dose was lower (30 mi-
nutes a day, three times a week for four weeks [10]), it
remains possible that adherence to FST in this present
feasibility trial could have been higher. In a subsequent
trial, therefore, additional improvements in adherence
will be sought through reinforcing emphasis on strat-
egies to empower participants, such as shared decision-
making for goal setting (including identification of mo-
tivation factors), providing personalized information to
enhance an individual’s own responsibility for rehabili-
tation, and consideration of emotional states that could
impact on participation [35,36].
Acceptability of both forms of FST is evident from the
data generated by interviews with participants in this
feasibility trial. Indeed, only one participant withdrew
from the trial for a reason directly related to treatment
allocation and that was because of a preference for the
other form of FST.
Conclusions
With modifications to the protocol, particularly in re-
spect of the recruitment strategy, this line of research
can continue to a fully powered, randomized, controlled
clinical trial. Pretrial focus groups with stroke survivors
meeting the trial criteria will be held to inform a deci-
sion as to whether or not to use telephone reminders
for non-respondents to invitation letters. In addition,
consultation with health professionals working in stroke
services in both acute and community settings will
inform the procedure for ensuring that neuroimaging
data is available in a timely manner to ensure precise
Mares et al. Trials 2014, 15:322 Page 10 of 11
http://www.trialsjournal.com/content/15/1/322characterization of people providing informed consent
to confirm their enrolment into the trial. The other re-
quired modification to the protocol will strengthen the
emphasis on strategies to empower individuals to par-
ticipate in the FST interventions with a view to maxi-
mizing adherence to allocated therapy.
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